Vivani Medical (NASDAQ:VANI – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.01), Zacks reports.
Vivani Medical Price Performance
Shares of Vivani Medical stock opened at $1.11 on Monday. The company has a market cap of $65.75 million, a PE ratio of -2.47 and a beta of 3.20. The firm has a fifty day moving average price of $1.14 and a two-hundred day moving average price of $1.21. Vivani Medical has a fifty-two week low of $1.03 and a fifty-two week high of $2.22.
Wall Street Analyst Weigh In
Separately, HC Wainwright reaffirmed a “buy” rating and issued a $4.00 price target on shares of Vivani Medical in a research report on Wednesday, March 26th.
Vivani Medical Company Profile
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Articles
- Five stocks we like better than Vivani Medical
- How to Use the MarketBeat Excel Dividend Calculator
- Lululemon Pulls Back Into Classic Dip-Buying Opportunity
- What Does Downgrade Mean in Investing?
- Cintas Delivers Earnings Beat, Signals More Growth Ahead
- How to Buy Gold Stock and Invest in Gold
- Analysts Say These 4 Low P/E Consumer Cyclical Stocks Are Buys
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
